|
|
||||||||
Letters |
New York State Department of Health, Wadsworth Center, Albany, NY 12201-0509
To the Editor:
In their letter, Lukacs et al. present an interesting modification and improvement of the procedure described previously by Bellisario et al. (1), using the Luminex Xmap system to simultaneously assay for thyroxine (T4) and thyrotropin (TSH) in a Guthrie specimen. Their innovation builds on the earlier work and, importantly, negates the necessity for multiple wash steps while maintaining acceptable sensitivity and specificity. This will greatly facilitate automation of these tests, an important aspect for newborn screening programs, in which thousands of specimens are processed each day. The concept of simultaneous measurement of T4 and TSH enhances the specificity of hypothyroidism screening in newborns, at the same time reducing the workload by combining two tests into a single procedure. Their comments concerning the use of a TSH:T4 ratio are interesting and worthy of follow-up.
The use of ratios such as this has been helpful in increasing the specificity of other newborn assays, such as for phenylketonuria (PKU) (2). With the addition of a bead-based test for 17-hydroxyprogesterone, the serum marker for congenital adrenal hyperplasia, and immunoreactive trypsinogen, the serum marker for cystic fibrosis, to the T4/TSH assay, a complete endocrine panel for newborn screening could be accomplished in this system in a single assay tube. This multiplex testing offers newborn screening programs tremendous opportunities for expanding the screening panel without increasing the workload.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |